Burosumab 20mg/1ml solution for injection vials
NHS hospitals in England used £19,932,704 of indicative cost of Burosumab 20mg/1ml solution for injection vials in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 14.9% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Burosumab 20mg/1ml solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Burosumab 20mg/1ml solution for injection vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Univ Hpls Bristol Nhs Foundation Trust | £2,148,256 |
| Manchester University Nhs Ft | £1,813,152 |
| University College London Foundation Tr | £1,543,872 |
| Royal National Ortho.hospital Trust | £1,442,144 |
| Nottingham University Hospitals Trust | £1,035,232 |
| Oxford University Hospitals Nhs Ft | £957,440 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £921,536 |
| Alder Hey Childrens Nhs Foundation Trust | £885,632 |
| Sheffield Children's Nhs Ft | £748,000 |
| University Hospital Southampton Nhs Ft | £622,336 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.